EA200701602A1 - Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича - Google Patents

Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича

Info

Publication number
EA200701602A1
EA200701602A1 EA200701602A EA200701602A EA200701602A1 EA 200701602 A1 EA200701602 A1 EA 200701602A1 EA 200701602 A EA200701602 A EA 200701602A EA 200701602 A EA200701602 A EA 200701602A EA 200701602 A1 EA200701602 A1 EA 200701602A1
Authority
EA
Eurasian Patent Office
Prior art keywords
analysis
behavior
treatment
subject
autism
Prior art date
Application number
EA200701602A
Other languages
English (en)
Inventor
Франк Хоовер
Original Assignee
Типоген Ас
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Типоген Ас filed Critical Типоген Ас
Publication of EA200701602A1 publication Critical patent/EA200701602A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

В изобретении предложен способ прогнозирования лечения психического заболевания, в частности аутизма или церебрального паралича, у субъекта-человека методом прикладного анализа поведения, при котором анализируют образец ткани или жидкости организма указанного субъекта на присутствие или отсутствие химического маркера, указывающего на вероятность успеха или неудачи лечения психического заболевания методом прикладного анализа поведения, и, возможно, основанное на указанном анализе начало, продолжение или прекращение лечения указанного субъекта методом прикладного анализа поведения. Данный образец предпочтительно представляет собой образец мочи, и предпочтительными прогностическими маркерами являются производные глютена, индолил-3-акрилоилглицин (IAG), стимулятор захвата серотонина, β-казоморфинамиды, глиадиноморфин, β-казоморфины, дельторфины, деморфин, глютеморфин, глютеновые экзофины, соединения с молекулярной массой 687 дальтон.
EA200701602A 2005-02-28 2006-02-28 Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича EA200701602A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0504096.9A GB0504096D0 (en) 2005-02-28 2005-02-28 Method
PCT/GB2006/000699 WO2006090185A1 (en) 2005-02-28 2006-02-28 Method of prognosis of mental diseases, e. g. autism and cerebral palsy

Publications (1)

Publication Number Publication Date
EA200701602A1 true EA200701602A1 (ru) 2008-02-28

Family

ID=34430346

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701602A EA200701602A1 (ru) 2005-02-28 2006-02-28 Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича

Country Status (12)

Country Link
US (1) US20090011452A1 (ru)
EP (1) EP1853922A1 (ru)
JP (1) JP2008532033A (ru)
CN (1) CN101189522A (ru)
AU (1) AU2006217658A1 (ru)
CA (1) CA2598945A1 (ru)
EA (1) EA200701602A1 (ru)
GB (1) GB0504096D0 (ru)
IL (1) IL185554A0 (ru)
NO (1) NO20074515L (ru)
WO (1) WO2006090185A1 (ru)
ZA (1) ZA200707230B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078950A2 (en) * 2007-12-14 2009-06-25 Cornell University Method of determing excretion of sodium and other analytes
US8703424B2 (en) 2010-03-22 2014-04-22 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
EP2564194B1 (en) 2010-04-29 2019-07-10 Wisconsin Alumni Research Foundation Metabolic biomarkers of autism
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
MX2016000293A (es) 2013-07-09 2016-06-21 Stemina Biomarker Discovery Inc Biomarcadores del trastrono del espectro autista.
US20150294081A1 (en) 2014-04-11 2015-10-15 Synapdx Corporation Methods and systems for determining autism spectrum disorder risk
US9176113B1 (en) 2014-04-11 2015-11-03 Synapdx Corporation Methods and systems for determining autism spectrum disorder risk
JP6800846B2 (ja) 2014-10-30 2020-12-16 カリフォルニア インスティチュート オブ テクノロジー 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
US10111914B2 (en) 2014-10-30 2018-10-30 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
US10525020B2 (en) 2015-02-11 2020-01-07 Laboratory Corporation Of America Holdings Metabolic markers of attention deficit hyperactivity disorder
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
EP3465212A4 (en) 2016-05-23 2020-01-08 California Institute of Technology REGULAR FLORAL REGULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
US10001103B1 (en) 2016-12-15 2018-06-19 Borgwarner, Inc. System with multiple starters and smart relay
EP3624782A4 (en) 2017-05-15 2021-05-05 Axial Biotherapeutics, Inc. INHIBITORS OF MICROBIALLY INDUCED AMYLOID
RU2698634C1 (ru) * 2019-03-18 2019-08-28 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогнозирования риска развития детского церебрального паралича у детей, родившихся в сроке сверхранних преждевременных родов, на первом году жизни
CN115616227B (zh) * 2022-11-18 2023-05-16 四川大学华西医院 吲哚-3-丙烯酰甘氨酸检测试剂的用途、诊断或辅助诊断慢性阻塞性肺病的试剂盒及系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197746B1 (en) * 1998-05-19 2001-03-06 Repligen Corporation Method of using secretin for treating autism
CA2273683A1 (en) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Diagnostic markers for human disorders
US6534063B1 (en) * 1999-12-17 2003-03-18 Joan M. Fallon Methods for treating pervasive development disorders
JP4299243B2 (ja) * 2002-07-04 2009-07-22 田辺三菱製薬株式会社 統合失調症の検査、診断方法
FR2857452B1 (fr) * 2003-07-11 2005-09-30 Univ Rabelais Francois Test de depistage de l'autisme, methode de selection de patients repondant audit test et utilisation des medicaments activateurs de canaux bkca pour le traitement de ladite maladie
WO2005019474A2 (en) * 2003-08-22 2005-03-03 Integragen Human autism susceptibility gene and uses thereof

Also Published As

Publication number Publication date
NO20074515L (no) 2007-09-06
GB0504096D0 (en) 2005-04-06
WO2006090185A1 (en) 2006-08-31
JP2008532033A (ja) 2008-08-14
CA2598945A1 (en) 2006-08-31
EP1853922A1 (en) 2007-11-14
ZA200707230B (en) 2008-11-26
CN101189522A (zh) 2008-05-28
AU2006217658A1 (en) 2006-08-31
US20090011452A1 (en) 2009-01-08
IL185554A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
EA200701602A1 (ru) Способ прогнозирования психических заболеваний, например аутизма и церебрального паралича
NO20030251L (no) Fremgangsmåte for differensiering mellom biologiske tilstander basert på skjulte mönstre fra biologiske data
WO2006073682A3 (en) Diagnostic test
WO2006119292A3 (en) Methods for detection of biological substances
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
WO2008069975A3 (en) Methods of using f-spondin as a biomarker for cartilage degenerative conditions
EP2306192A3 (en) Risk Markers For Cardiovascular Disease
BRPI0809885B8 (pt) artigo absorvente, e, método para detectar presença de um analito na urina
WO2005114190A3 (en) Methods of identifying biomarkers
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
EE200300005A (et) Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
WO2006063042A3 (en) Selecting patients for therapy with a her inhibitor
ATE438853T1 (de) Diagnostische testvorrichtung
WO2004069174A3 (en) Monitoring and treatment of amyotrophic lateral sclerosis
NO994365L (no) Forutsigelse av koronararterie-sykdom
NO20076656L (no) Forbedrede immunoassay metoder
WO2006103570A8 (en) Diagnosis method of alcoholic or non-alcoholic steato-hepatitis using biochemical markers
HK1184534A1 (zh) 通過測定半乳糖苷凝集素- 或者血小板反應蛋白- 的水平鑒定具有發生心力衰竭風險的受試者的方法
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
ATE525657T1 (de) Analytisches einweg-mikroprozessorgerät
BR9804648A (pt) Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos.
EP1698898A3 (en) Prognostic, diagnostic and therapeutic significance in detecting and using TIN-antigen (Tubulo-Interstitial nephritis antigen) and its segments
ATE458070T1 (de) Verfahren und zusammensetzungen zur analyse von urinproben bei der diagnose und behandlung von nierenerkrankungen
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient